Intralesional rose bengal in melanoma elicits tumor immunityviaactivation of dendritic cells by the release of high mobility group box 1-Reference-Cited by-同舟云学术

Intralesional rose bengal in melanoma elicits tumor immunityviaactivation of dendritic cells by the release of high mobility group box 1

Published:2016-05-09 Issue:25 Volume:7 Page:37893-37905
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Hao¹,Innamarato Pasquale Patrick¹,Kodumudi Krithika¹,Weber Amy¹,Nemoto Satoshi²,Robinson John L.³,Crago Georgina⁴,McCardle Timothy⁵,Royster Erica⁶,Sarnaik Amod A.¹⁴,Pilon-Thomas Shari¹⁴

Affiliation:

1. Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

2. Department of Translational Science, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

3. Flow Cytometry Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

4. Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

5. Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

6. Department of Cutaneous Data Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intralesional and Infusional Updates for Metastatic Melanoma;Cancers;2024-05-22

2. Identification and In Vivo Validation of Unique Anti-Oncogenic Mechanisms Involving Protein Kinase Signaling and Autophagy Mediated by the Investigational Agent PV-10;Cancers;2024-04-16

3. Design and functional characterization of Salmo salar TLR5 agonist peptides derived from high mobility group B1 acidic tail;Fish & Shellfish Immunology;2024-03

4. Needle before Scalpel: Considering the Role of Intratumoral Therapy in Melanoma;Dermatologic Therapy;2024-01

5. Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress;Cancers;2023-02-23